Phenoconversion of drug-metabolizing enzymes and its mechanism during inflammatory conditions / 国际药学研究杂志
Journal of International Pharmaceutical Research
;
(6): 541-550, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-478267
ABSTRACT
Inflammatory conditions are associated with most diseases. Phenoconversion of drug-metabolizing enzymes(DME) leads to altered drug metabolism and disposition. It has profound impact on the pharmacotherapy of widely used clinically relevant medications in terms of safety and efficacy. More and more evidence has proved that elevated levels of proinflammatory cytokines may downregulate the expression and the activity of many Phase Ⅰ and Phase Ⅱ DME, which are involved in complex regulation mechanisms of drug disposition. The aim of this review is to present the recent findings in this area. Clinical practice based on personalized medicine according to DME phenotype with improved safety and efficiency can yield robust efficacy outcomes of drug treatment and has promising future prospects.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of International Pharmaceutical Research
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS